هذه القائمة تحليل مبني على أحداث السوق الأخيرة. ليست توصية استثمارية.
حول
Stemcell United Limited, together with its subsidiaries, engages in the sourcing, producing, marketing, and selling of traditional medicines in Australia, Singapore, Greater China, and Malaysia. Its products include Cannabis Sativa, an industrial hemp; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Caulerpa Lentillifera, a sea grape extract. The company has a collaboration agreement with Temasek Polytechnic of Singapore to conduct joint research on the application of plant stem cell technology to the cultivation and commercial farming of seagrapes in Singapore; collaboration with Yunnan Hongyi Agriculture Development Co Ltd; and collaboration agreement with the University of Science to study the cultivation of seagrapes through the use of land-based and urban farming techniques. The company was formerly known as On Q Group Limited and changed its name to Stemcell United Limited in September 2015. Stemcell United Limited was incorporated in 1984 and is headquartered in Sydney, Australia.